Want to hire this expert for a project? Request a quote for free.
Profile Details
Subject Matter Expertise
Services
Work Experience
Scientist
Stanford University
November 2018 - Present
Scientist
BMS
October 2017 - October 2018
Postdoc & research staff
Stanford University
September 2014 - October 2017
Postdoc & instructor
Emory University
February 2011 - August 2014
Education
PhD
Laval University
August 2005 - December 2010
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
Ma, J., Pichavant, C., du Bois, H., Bhakta, M., Calos, M.P., Ma, J., Pichavant, C., du Bois, H., Bhakta, M., Calos, M.P.(2017). DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B . Molecular Therapy - Methods and Clinical Development. 7. p. 123-131.
Pichavant, C., Burkholder, T.J., Pavlath, G.K.(2016). Decrease of myofiber branching via muscle-specific expression of the olfactory receptor mOR23 in dystrophic muscle leads to protection against mechanical stress . Skeletal Muscle. 6. (1).
Simionescu-Bankston, A., Pichavant, C., Canner, J.P., Apponi, L.H., Wang, Y., Steeds, C., Olthoff, J.T., Belanto, J.J., Ervasti, J.M., Pavlath, G.K.(2015). Creatine kinase B is necessary to limit myoblast fusion during myogenesis . American Journal of Physiology - Cell Physiology. 308. (11). p. C919-C931.
Pichavant, C., Pavlath, G.K.(2014). Incidence and severity of myofiber branching with regeneration and aging . Skeletal Muscle. 4. (1).
Pichavant, C., Gargioli, C., Tremblay, J.P.(2011). Intramuscular transplantation of muscle precursor cells over-expressing MMP-9 improves transplantation success . PLoS Currents.
Pichavant, C., Aartsma-Rus, A., Clemens, P.R., Davies, K.E., Dickson, G., Takeda, S., Wilton, S.D., Wolff, J.A., Wooddell, C.I., Xiao, X., et al.(2011). Current status of pharmaceutical and genetic therapeutic approaches to treat DMD . Molecular Therapy. 19. (5). p. 830-840.
Pichavant, C., Chapdelaine, P., Cerri, D.G., Dominique, J.-C., Quenneville, S.P., Skuk, D., Kornegay, J.N., Bizario, J.C., Xiao, X., Tremblay, J.P.(2010). Expression of dog microdystrophin in mouse and dog muscles by gene therapy . Molecular Therapy. 18. (5). p. 1002-1009.
Pichavant, C., Chapdelaine, P., Cerri, D.G., Bizario, J.C.S., Tremblay, J.P.(2010). Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles . Human Gene Therapy. 21. (11). p. 1591-1601.
Chapdelaine, P., Pichavant, C., Rousseau, J., Pâques, F., Tremblay, J.P.(2010). Meganucleases can restore the reading frame of a mutated dystrophin . Gene Therapy. 17. (7). p. 846-858.
Stephan, L., Pichavant, C., Bouchentouf, M., Mills, P., Camirand, G., Tagmouti, S., Rothstein, D., Tremblay, J.P.(2006). Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use . Cell Transplantation. 15. (8-9). p. 835-846.
BOOK
Pichavant, C., Tremblay, J.P.(2012). Generation of lentiviral vectors for use in skeletal muscle research . Methods in Molecular Biology. 798. p. 285-295.